🇧🇷·3d agoIndustry
A EMS assume a gestão da marca de probióticos Culturelle® no Brasil e avança em uma categoria estratégica de suplementos alimentares dentro do mercado farmacêutico
Publisher
E
EMS Pharma News
Brazil
This page provides a limited summary and publisher metadata to support discovery before sending readers to the original article.
Read originalIn-platform summary, original article off-platform
This page presents the title, publisher metadata, and a limited summary excerpt to help users judge relevance first. Full-text reading stays on the publisher's original site.
Source route
Continue on ems.com.br
Leave the platform to read the original full article on the publisher site.
Source: EMS Pharma News
Scope: Industry
Related coverage
More related coverage
Allogene Therapeutics·2d ago
Allogene Therapeutics to Announce Interim Futility Analysis Data from its Pivotal Phase 2 ALPHA3 Trial with Cemacabtagene Ansegedleucel (Cema-Cel) in First-Line Consolidation LBCL on Monday, April 13, 202
Adaptive Biotechnologies·2d ago
Predicting T Cell Recognition: New Insights from Large-Scale Activation Data
A study accepted to ML4H 2025 explores whether sequence-based models trained on large-scale T-cell a...
eXoZymes·2d ago
eXoZymes CCO, Damien Perriman, outlines NCTx strategy and the commercial path for cell-free biomanufacturing on Grow Everything podcast
Idorsia·3d ago